Rockwell Medical Enters Product Purchase Agreement With AProvider Of Dialysis Products And Services; Partnership Expected To Generate Upwards Of $10M In Net Sales For Company In 2025
Rockwell Medical Enters Product Purchase Agreement With AProvider Of Dialysis Products And Services; Partnership Expected To Generate Upwards Of $10M In Net Sales For Company In 2025
Rockwell Medical與一款透析產品和服務的提供商簽署了產品購買協議；預計該合作伙伴關係將在2025年爲公司創造超過1000萬美元的淨銷售額。
Under the terms of the Agreement, Rockwell Medical will supply the Customer with the Company's liquid bicarbonate hemodialysis concentrates product, SteriLyte.
根據協議，Rockwell Medical將向客戶提供公司的液體碳酸氫鈉透析濃縮液產品Sterilyte。
The Agreement will remain in effect for three years with the option to renew for two additional one-year periods and is expected to generate upwards of $10 million in net sales for the Company in the first year, a portion of which was not included in Rockwell Medical's previously disclosed revenue estimates for 2025, with incremental price increases each subsequent year.
該協議將持續三年，並有權選擇續約兩個額外的一年期，並預計在第一年爲公司產生超過1000萬的淨銷售額，其中一部分未包含在Rockwell Medical之前披露的2025年度營業收入估計中，後續每年還將有增價。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間